Two Nucleotide Analogs for HBV Adefovir (left) and Tenofovor (right). These are the active agents that the Hepsera and Viread prodrugs, respectively, become in vivo.
These molecules are structurally similar to one another to roughly the same degree that the two nucleoside analogs, Tyzeka and Clevudine (#msg-20216885) are to one another.
Market Data 
Markets 
AI
